Not yet time to change the guidelines for monitoring methotrexate liver toxicity: They have served us well

Journal of Rheumatology

Volumn 29, Issue 8, 2002, Pages 1590-1592

  Kremer, Joel M ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; ANTIRHEUMATIC AGENT; ASPARTATE AMINOTRANSFERASE;

DRUG SAFETY; EDITORIAL; HUMAN; LIVER BIOPSY; LIVER TOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; BLOOD; DRUG MONITORING; METHODOLOGY; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; TOXIC HEPATITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ASPARTATE AMINOTRANSFERASES; DRUG MONITORING; HEPATITIS, TOXIC; HUMAN; METHOTREXATE; PRACTICE GUIDELINES; RHEUMATOLOGY; HUMANS;

EID: 0036021120     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Liver biopsies from psoriatics related to methotrexate therapy: Findings in post-methotrexate liver biopsies from 160 psoriatics
2. Methotrexate-induced liver cirrhosis studies including serial liver biopsies during continued treatment
3. Methotrexate hepatotoxicity in psoriasis: Consideration of liver biopsies at regular intervals
4. Methotrexate guidelines - Revised
5. A long-term prospective study of the use of methotrexate in long-term therapy for rheumatoid arthritis
6. Significant changes in serum AST across hepatic histological biopsy grades: Prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis
7. Electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis. Correlation with light microscopic findings
8. Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Followup over long treatment intervals and correlation with clinical and laboratory variables
9. Liver toxicity does not have to follow methotrexate therapy of patients with rheumatoid arthritis
10. A debate: Should patients with rheumatoid arthritis on methotrexate undergo liver biopsies?
11. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity
12. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate treated rheumatoid arthritis patients
13. Monitoring MTX hepatic toxicity in rheumatoid arthritis: Is it time to update the guidelines?
14. A long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: Update after a mean of 90 months
15. Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis
16. Methotrexate-induced liver abnormalities in rheumatoid arthritis
17. Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate
18. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-Month update
19. Rational use of new and existing disease-modifying agents in rheumatoid arthritis
20. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates